首页> 美国卫生研究院文献>Journal of Thoracic Disease >Valve therapy in patients with emphysematous type of chronic obstructive pulmonary disease (COPD): from randomized trials to patient selection in clinical practice
【2h】

Valve therapy in patients with emphysematous type of chronic obstructive pulmonary disease (COPD): from randomized trials to patient selection in clinical practice

机译:气肿型慢性阻塞性肺疾病(COPD)患者的瓣膜治疗:从随机试验到临床实践中的患者选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In recent years a number of endoscopic methods have emerged to treat patients with severe emphysematous type of chronic obstructive pulmonary disease (COPD), who are primarily symptomatic due to hyperinflation despite optimal medical management. Of these techniques, implantation of endobronchial one-way valves into targeted airways of isolated emphysematous lobes appears to be one of the most promising innovations. Results from randomized controlled trials of valve therapy for emphysema show consistent benefits in terms of lung function, exercise capacity, symptoms, and quality of life. This review aims to provide a comprehensive summary of the currently available scientific data, discussion of typical treatment related side effects, and recommendations for patient selection in clinical practice.
机译:近年来,已经出现了许多内窥镜检查方法来治疗患有严重气肿型慢性阻塞性肺疾病(COPD)的患者,尽管进行了最佳医疗管理,但这些患者的症状主要是由于恶性通气。在这些技术中,将支气管内单向瓣膜植入孤立的气肿性肺叶的目标气道似乎是最有希望的创新之一。瓣膜治疗肺气肿的随机对照试验结果显示,在肺功能,运动能力,症状和生活质量方面均具有一致的益处。这篇综述旨在提供当前可用科学数据的全面摘要,讨论典型的治疗相关副作用,并为临床实践中的患者选择提供建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号